Kevin D. Burris Quantitative Biology Eli Lilly and Company Biography Publications Institution JoVE Articles Kevin D. Burris has not added a biography. If you are Kevin D. Burris and would like to personalize this page please email our Author Liaison for assistance. Publications Design, Synthesis and Evaluation of Constrained Tetrahydroimidazopyrimidine Derivatives As Antagonists of Corticotropin-releasing Factor Type 1 Receptor (CRF1R) Bioorganic & Medicinal Chemistry Letters. Mar, 2010 | Pubmed ID: 20185312 Oxime Carbamate--discovery of a Series of Novel FAAH Inhibitors Bioorganic & Medicinal Chemistry Letters. Feb, 2010 | Pubmed ID: 20036536 Interaction of the Novel Antipsychotic Aripiprazole with 5-HT1A and 5-HT 2A Receptors: Functional Receptor-binding and in Vivo Electrophysiological Studies Psychopharmacology. Feb, 2007 | Pubmed ID: 17242925 Synthesis, Structure-activity Relationships, and Anxiolytic Activity of 7-aryl-6,7-dihydroimidazoimidazole Corticotropin-releasing Factor 1 Receptor Antagonists Bioorganic & Medicinal Chemistry Letters. Sep, 2005 | Pubmed ID: 15990298 Aripiprazole's Low Intrinsic Activities at Human Dopamine D2L and D2S Receptors Render It a Unique Antipsychotic European Journal of Pharmacology. May, 2005 | Pubmed ID: 15894311 Mechanism of Action of Aripiprazole Predicts Clinical Efficacy and a Favourable Side-effect Profile Journal of Psychopharmacology (Oxford, England). Sep, 2004 | Pubmed ID: 15358981 The Novel Antipsychotic Aripiprazole is a Partial Agonist at Short and Long Isoforms of D2 Receptors Linked to the Regulation of Adenylyl Cyclase Activity and Prolactin Release Brain Research. Apr, 2004 | Pubmed ID: 15019558 Synthesis and SAR Exploration of Dinapsoline Analogues Bioorganic & Medicinal Chemistry. Feb, 2004 | Pubmed ID: 14759732 2-arylaminothiazoles As High-affinity Corticotropin-releasing Factor 1 Receptor (CRF1R) Antagonists: Synthesis, Binding Studies and Behavioral Efficacy Bioorganic & Medicinal Chemistry Letters. Nov, 2003 | Pubmed ID: 14592493 Diminished Catalepsy and Dopamine Metabolism Distinguish Aripiprazole from Haloperidol or Risperidone European Journal of Pharmacology. Jul, 2003 | Pubmed ID: 12860477 (+)-Dinapsoline: an Efficient Synthesis and Pharmacological Profile of a Novel Dopamine Agonist Journal of Medicinal Chemistry. Aug, 2002 | Pubmed ID: 12166939 Aripiprazole, a Novel Antipsychotic, is a High-affinity Partial Agonist at Human Dopamine D2 Receptors The Journal of Pharmacology and Experimental Therapeutics. Jul, 2002 | Pubmed ID: 12065741 Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications Jason M. Conley1, Tarsis F. Brust1, Ruqiang Xu1, Kevin D. Burris2, Val J. Watts1 1Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 2Quantitative Biology, Eli Lilly and Company JoVE 51218 Bioengineering
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications Jason M. Conley1, Tarsis F. Brust1, Ruqiang Xu1, Kevin D. Burris2, Val J. Watts1 1Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 2Quantitative Biology, Eli Lilly and Company JoVE 51218 Bioengineering
